Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

The risk of having shingles goes up with age, and people with compromised immune systems are more likely to be diagnosed with it. There is currently one vaccine that can help prevent shingles in the ...

(I still have significant neuropathy with lesions on my spinal cord.) So, we decided against giving me the shingles vaccine. Do you agree with this approach? How strong is the evidence that ...

Who is eligible for a Covid-19 vaccine booster? The vaccine is the best way to protect yourself against serious illness and hospitalisation from Covid-19. That’s why people at higher risk, such as ...

There was also no statistically significant increased risk of serious CNS demyelinating and inflammatory diseases or GBS in the 30-day period following vaccination and no specific syndrome or ...

Russia has developed a cancer vaccine for patients. Representational Image/Pixabay Russia is all set to roll out a vaccine against cancer in the New Year. It will be available to patients for free ...

If you are 50 years and older, don’t forget to ask about your risk for shingles and about vaccination.